From Efficacy to Access: The Importance of Oncology Business Acumen

Prepare to empower your teams with the knowledge to navigate the complex landscape of oncology therapies, focusing on the intersection of clinical efficacy and healthcare economics.

Join us for this 30-minute LTEN webinar, sponsored by CMR Institute, as we explore how clinical research outcomes not only influence medical decisions, but also pave the way for enhancing patient care through strategic business insights. You will learn the critical role of oncology business acumen in addressing the concerns of key stakeholders, ensuring broader market access and effectively discussing cost, reimbursement and patient access issues.

In the webinar, you will learn:

1. The ways in which clinical research outcomes are used to drive decisions and support the patient journey.
2. How oncology business acumen can help meet the needs of key stakeholders and improve market access.
3. To prepare your teams to navigate conversations around cost, reimbursement and patient access to oncology therapies.

You’ll learn from and interact with:

• Ivo Abraham, Professor of Pharmacy, Medicine and Clinical Translational Sciences, University of Arizona
• Gary Rice, Senior Advisor, Specialty and Clinical Strategy, MedImpact Healthcare Systems
• Sharon Lustig (Moderator), Senior Vice President, Client Solutions, CMR Institute

Register today for this free, LTEN webinar.  Not an LTEN member? Join today and realize the value.

Presenters: